A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

PHASE3CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Mild to Moderate Persistent Allergic Rhinitis
Interventions
DRUG

Mometasone furoate

DRUG

Mometasone furoate

Trial Locations (1)

Unknown

IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada, São Paulo

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY